Cure My Disease

Don't miss your cure!

 Log in / Sign up

Phone coaching helps kids with diabetes manage blood sugar better

NCT ID NCT03565770

Disease control Sponsor: University Hospital, Lille Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested a personalized telemedicine coaching program for children with type 1 diabetes who have difficulty adjusting their insulin therapy. Over 100 children received phone and secure message coaching from nurses for 6 months. The goal was to improve blood sugar control (measured by HbA1c) and help families manage the condition more effectively.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

106 people

The number who actually took part.

Started

Sep 2018

Finished

Jun 2021

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

Up to 18 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Less than 18 years old when coaching starts. * Any diabetic patient (girl or boy) who doesn't master the adjustments of the treatment according to the investigator's judgment (non-adaptations of the treatment between 2 consultations or mistakes in adapting the insulin doses, not taking properly into account previous days tendencies, food, or activities) and/or average HbA1c of more than 8% during the last year. * The patient, his 2 parents or legal representatives all agree to participate in the research * Absence of justice protection measures * Good predictable observance of the protocol * Family can be reached by phone during the coaching timetables working hours or must be listed on the platform line " MyDiabby ". Exclusion Criteria: * Non auto-immun diabetes * Major understanding difficulties from the relatives (difficulties in understanding French or what anticipatory adaptation means) * The child or parents or legal representatives refuse to participate and to sign a consent * Contact on the phone or on the platform impossible according to the protocol procedures * Patient non-registered under Social Security * Patient under justice protection measures

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Diabetes TYPE1 are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

type 1 diabetes mellitus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Diabetes TYPE1

Contacts and locations

Locations

  • Hôpital Jeanne de Flandres

    Lille, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.